Norges Bank acquired a new stake in shares of Cencora, Inc. (NYSE:COR – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,435,250 shares of the company’s stock, valued at approximately $822,506,000. Norges Bank owned about 1.26% of Cencora at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Cencora in the fourth quarter worth $28,892,000. Triglav Investments D.O.O. grew its stake in shares of Cencora by 140.9% in the fourth quarter. Triglav Investments D.O.O. now owns 33,000 shares of the company’s stock worth $11,146,000 after acquiring an additional 19,300 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in shares of Cencora in the fourth quarter worth $639,000. Principia Wealth Advisory LLC grew its stake in shares of Cencora by 3,462.5% in the fourth quarter. Principia Wealth Advisory LLC now owns 285 shares of the company’s stock worth $96,000 after acquiring an additional 277 shares during the last quarter. Finally, National Pension Service grew its stake in shares of Cencora by 6.3% in the fourth quarter. National Pension Service now owns 720,381 shares of the company’s stock worth $243,309,000 after acquiring an additional 42,652 shares during the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently commented on COR. Barclays increased their target price on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. William Blair initiated coverage on Cencora in a research note on Tuesday, April 28th. They set a “market perform” rating on the stock. UBS Group lifted their target price on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Wells Fargo & Company reduced their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Finally, Weiss Ratings lowered Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and a consensus price target of $380.25.
Cencora Stock Up 0.6%
Cencora stock opened at $269.21 on Friday. The firm has a market cap of $52.38 billion, a price-to-earnings ratio of 20.65, a PEG ratio of 1.24 and a beta of 0.64. The stock has a fifty day simple moving average of $298.56 and a two-hundred day simple moving average of $333.91. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40.
Cencora (NYSE:COR – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the previous year, the business posted $4.42 EPS. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.
Cencora Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th. Cencora’s dividend payout ratio (DPR) is presently 18.40%.
Cencora declared that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
Cencora Company Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Articles
- Five stocks we like better than Cencora
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
